The Effects of Restrictive IV Fluid Volume on Mortality and Other Patient Important Outcomes

Classic was an investigator initiated international stratified parallel group open-table assuity. Patients were randomly assigned to one of two intervention groups labeled restrictive IV fluid or standard IV fluid. The trial was conducted throughout 31 ice use in eight countries as you see here and patients were predominantly enrolled in the Scandinavian countries. There is no firm evidence for neither benefit or harm, so that was no statistically significant difference in mortality, serious adverse events or other patient important outcomes.